Download PDF
Planta Med 2010; 76(6): 572-582
DOI: 10.1055/s-0029-1240602
Pharmacology
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Cardiac and Electrophysiological Effects of Primary and Refined Extracts from Leonurus cardiaca L. (Ph.Eur.)

Malte Ritter1 [*] , Kerstin Melichar1 [*] , Sabine Strahler2 , Kenny Kuchta2 , Jan Schulte1 , Laura Sartiani3 , Elisabetta Cerbai3 , Alessandro Mugelli3 , Friedrich-Wilhelm Mohr1 , Hans Wilhelm Rauwald2 , Stefan Dhein1
  • 1Clinic for Cardiac Surgery, University of Leipzig, Leipzig, Germany
  • 2Department of Pharmaceutical Biology, University of Leipzig, Leipzig, Germany
  • 3Department of Pharmacology, University of Florence, Florence, Italy
Further Information

Publication History

received June 9, 2009 revised October 14, 2009

accepted October 18, 2009

Publication Date:
16 November 2009 (online)

    Permissions and Reprints

Corrected by:

Erratum for: Cardiac and Electrophysiological Effects of Primary and Refined Extracts from Leonurus cardiaca L. (Ph.Eur.)Planta Med 2010; 76(06): E11-E11
DOI: 10.1055/s-0029-1240698

Abstract

Although several antiarrhythmic drugs of chemical origin are in clinical use since decades, their application is often limited by their adverse effects and especially by their inherited proarrhythmic risk, which can lead to a significantly increased mortality in patients receiving these compounds. On the other hand, aqueous extracts from the aerial parts of the European Lamiaceae Leonurus cardiaca (Ph.Eur.) have been used for centuries as a remedy against tachyarrhythmia and other cardiac disorders. Nevertheless, a scientific basis for the claim of direct cardiac electrophysiological, antiarrhythmic, or functional effects of Leonurus cardiacae herba (LCH) preparations has not been established until now. In order to enrich the active constituents from the primary extract which was tested as the most cardioactive, namely the aqueous Soxhlet extract, and to eliminate undesired substances such as the dichloromethanic fraction or potassium, a bioassay guided fractionation procedure was applied, resulting in the development of a Leonurus cardiaca refined extract (LCRE) which was characterised together with Leonurus crude extracts by a newly developed gradient elution HPLC fingerprint analysis for separation and quantification of six major phenolics as well as by qNMR for determining the stachydrine content. This refined extract was applied intracoronarily in isolated rabbit hearts perfused according to the Langendorff technique. Mapping experiments with 256 electrodes on the heart surface showed a reduction of left ventricular pressure and an increase of relative coronary flow at concentrations of 1.0 and 2.0 mg/mL LCRE. Furthermore, the PQ-interval was prolonged and both the basic cycle length and the activation recovery interval increased. In addition, voltage-clamp measurements were performed on the following cell models in order to characterise the electrophysiological profile of LCRE: neonatal rat ventricular cardiomyocytes to investigate the effect on INa and ICa.L, sinoatrial node cells and ventricular myocytes isolated from adult guinea pigs to test effects on If and action potential (AP) duration, as well as HERG-transfected HEK 293 cells to analyse the influence on the IK.r. In these voltage clamp experiments LCRE exerted a calcium-antagonistic activity by ICa.L blockade, reduced the repolarising current IK.r, and prolonged the AP-duration, while INa was not affected. Although LCRE displayed only weak effects on the If amplitude and voltage dependence, it significantly prolonged the activation time constant of If. Thus, LCRE acts on multiple electrophysiological targets, specifically ICa.L, IK.r, and If, observed both at whole organ and single cell level.

Key words

Leonurus cardiaca - Lamiaceae - refined extract - plant analysis - antianginal and antiarrhythmic effects - voltage clamp - epicardial mapping

References

  • 1 Barnes J, Anderson L A, Phillipson J D. Monograph motherwort. Herbal medicines. London; Pharmaceutical Press 2002: 354-356
    PubMedGoogle Scholar
  • 2 Arber A. Herbals: their origin and evolution. A chapter in the history of botany 1470 – 1670. Cambridge; Cambridge University Press 1938
    PubMedGoogle Scholar
  • 3 Wichtl M, Stahl-Biskup E. Herzgespannkraut – Leonuri cardiacae herba. Bracher F, Heisig P, Langguth P, Mutschler E, Rücker G, Scriba G, Stahl-Biskup E, Troschütz R Kommentar zum Europäischen Arzneibuch. Stuttgart; Wissenschaftliche Verlagsgesellschaft 2005: (19. Lfg.): 4.03/1833
    PubMedGoogle Scholar
  • 4 Orlandi E. Application of Leonurus cardiaca in therapy of children.  Lattante. 1950;  21 582-586
    PubMedGoogle Scholar
  • 5 Milkowska-Leyck K, Filipek B, Strzelecka H. Pharmacological effects of lavandulifolioside from Leonurus cardiaca.  J Ethnopharmacol. 2002;  80 85-90
    CrossrefPubMedGoogle Scholar
  • 6 Gaedcke F, Steinhoff B. Herbal medicinal products. Boca Raton; CRC Press 2003: 26-27
    PubMedGoogle Scholar
  • 7 Schulz V, Hänsel R, Tyler V E. Rational phytotherapy. Berlin, Heidelberg; Springer Verlag 1998: 6-8
    PubMedGoogle Scholar
  • 8 Dhein S, Muller A, Gerwin R, Klaus W. Comparative study on the proarrhythmic effects of some antiarrhythmic agents.  Circulation. 1993;  87 617-630
    PubMedGoogle Scholar
  • 9 Bazett H C. An analysis of time relations of electrocardiograms.  Heart. 1920;  7 353-370
    PubMedGoogle Scholar
  • 10 Zhou Z, Gong Q, Ye B, Fan Z, Makielski J C, Robertson G A, January C T. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.  Biophys J. 1998;  74 230-241
    CrossrefPubMedGoogle Scholar
  • 11 Ding W G, Toyoda F, Matsuura H. Blocking action of chromanol 293B on the slow component of delayed rectifier K(+) current in guinea-pig sino-atrial node cells.  Br J Pharmacol. 2002;  137 253-262
    CrossrefPubMedGoogle Scholar
  • 12 Cerbai E, Giotti A, Mugelli A. Characteristics of L-type calcium channel blockade by lacidipine in guinea-pig ventricular myocytes.  Br J Pharmacol. 1997;  120 667-675
    CrossrefPubMedGoogle Scholar
  • 13 Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation.  FASEB J. 2002;  16 1114-1116
    PubMedGoogle Scholar
  • 14 Cerbai E, Crucitti A, Sartiani L, De P P, Pino R, Rodriguez M L, Gensini G, Mugelli A. Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes.  Cardiovasc Res. 2000;  45 388-396
    CrossrefPubMedGoogle Scholar
  • 15 Knöss W, Zapp J. Accumulation of furanic labdane diterpenes in Marrubium vulgare and Leonurus cardiaca.  Planta Med. 1998;  64 357-361
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Erspamer V. Ricerche Farmacologiche sul Leonurus cardiaca L. e sul Leonurus marrubiastrum.  Arch Intern Pharmacodyn. 1948;  76 132-152
    PubMedGoogle Scholar
  • 17 Kozlova L M. On the phytochemistry of Leonurus quinquelobatus Gilib.  Farmatsiia. 1967;  16 23-26
    PubMedGoogle Scholar
  • 18 Strahler S. Erstmalige HPLC-Fingerprint-Analytik und Quantifizierung wirkungsrelevanter Phenylethanoide sowie weiterer phenolischer Marker in Herzgespannkraut (Leonuri cardiacae herba Ph.Eur.) unter besonderer Betrachtung dessen antiarrhythmischen Spezialextrakts [Diploma thesis]. Leipzig; University of Leipzig 2008
    PubMedGoogle Scholar
  • 19 Pennacchio M, Syah Y M, Ghisalberti E L, Alexander E. Cardioactive compounds from Eremophila species.  J Ethnopharmacol. 1996;  53 21-27
    CrossrefPubMedGoogle Scholar
  • 20 Kartnig T, Gruber A, Menzinger S. Flavonoid-O-glycosides from the herbs of Leonurus cardiaca.  J Nat Prod. 1985;  48 494
    CrossrefPubMedGoogle Scholar
  • 21 Pauli G F, Jaki B U, Lankin D C. Quantitative 1H NMR: development and potential of a method for natural products analysis.  J Nat Prod. 2005;  68 133-149
    CrossrefPubMedGoogle Scholar
  • 22 Hoppe U, Brandt M, Michels G, Lindner M. L-type calcium channel recording. Dhein S, Mohr FW, Delmar M Practical methods in cardiovascular research. Berlin, Heidelberg, New York; Springer Verlag 2004: 324-354
    PubMedGoogle Scholar
  • 23 Polder H R, Weskamp M, Linz K, Meyer R. Voltage-clamp and patch-clamp techniques. Dhein S, Mohr FW, Delmar M Practical methods in cardiovascular research. Berlin, Heidelberg, New York; Springer Verlag 2004: 272-323
    PubMedGoogle Scholar
  • 24 Kikuchi K, Nagatomo T, Abe H, Kawakami K, Duff H J, Makielski J C, January C T, Nakashima Y. Blockade of HERG cardiac K+ current by antifungal drug miconazole.  Br J Pharmacol. 2005;  144 840-848
    CrossrefPubMedGoogle Scholar
  • 25 DiFrancesco D. Funny channels in the control of cardiac rhythm and mode of action of selective blockers.  Pharmacol Res. 2006;  53 399-406
    CrossrefPubMedGoogle Scholar
  • 26 Cerbai E, Barbieri M, Mugelli A. Occurrence and properties of the hyperpolarization-activated current If in ventricular myocytes from normotensive and hypertensive rats during aging.  Circulation. 1996;  94 1674-1681
    PubMedGoogle Scholar
  • 27 Grace A A, Camm A J. Voltage-gated calcium-channels and antiarrhythmic drug action.  Cardiovasc Res. 2000;  45 43-51
    CrossrefPubMedGoogle Scholar
  • 28 Boyd R A, Giacomini J C, Giacomini K M. Species differences in the negative inotropic response of 1,4-dihydropyridine calcium channel blockers in myocardium.  J Cardiovasc Pharmacol. 1988;  12 650-657
    CrossrefPubMedGoogle Scholar
  • 29 Sanguinetti M C, Jurkiewicz N K. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.  J Gen Physiol. 1990;  96 195-215
    CrossrefPubMedGoogle Scholar
  • 30 Hancox J C, Levi A J, Witchel H J. Time course and voltage dependence of expressed HERG current compared with native “rapid” delayed rectifier K current during the cardiac ventricular action potential.  Pflugers Arch Eur J Physiol. 1998;  436 843-853
    PubMedGoogle Scholar
  • 31 Zünkler B J. Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects.  Pharmacol Ther. 2006;  112 12-37
    CrossrefPubMedGoogle Scholar
  • 32 El-Sherif N. The ventricular premature complex: mechanisms and significance – an update. Mandel J Cardiac arrhythmias. Philadelphia; J. B. Lippincott Co. 1987: 475-506
    PubMedGoogle Scholar
  • 33 Dhein S, Pejman P, Krusemann K. Effects of the I(K.ATP) blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion.  Eur J Pharmacol. 2000;  398 273-284
    CrossrefPubMedGoogle Scholar
  • 34 Hondeghem L M, Carlsson L, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.  Circulation. 2001;  103 2004-2013
    PubMedGoogle Scholar
  • 35 Hellestrand K J, Nathan A W, Bexton R S, Camm A J. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds.  Am J Cardiol. 1984;  53 30B-38B
    CrossrefPubMedGoogle Scholar
  • 36 DiFrancesco D. The contribution of the ‘pacemaker current (If) to generation of spontaneous activity in rabbit sino-atrial node myocytes.  J Physiol. 1991;  434 23-40
    PubMedGoogle Scholar
  • 37 Cerbai E, Barbieri M, Mugelli A. Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes isolated from hypertensive rats.  J Physiol. 1994;  481 585-591
    PubMedGoogle Scholar
  • 38 Janicsák G, Veres K, Kakasy A Z, Imre Máthé I. Study of the oleanolic and ursolic acid contents of some species of the Lamiaceae.  Biochem Syst Ecol. 2006;  34 392-396
    CrossrefPubMedGoogle Scholar
  • 39 Makarov V G, Aleksandrova A E, Shikov A N, Shiler L V, Ryzhenkov V E. Experimental and clinical study of preparation iridol action on the central nervous system.  Eksp Klin Farmakol. 2006;  69 23-25
    PubMedGoogle Scholar
  • 40 Kubota S, Nakashima S. The study of Leonurus sibiricus L.: chemical study of the alkaloid (Leonurin) isolated from Leonurus sibiricus L. and pharmacological study of the alkaloid “Leonurin” isolated from Leonurus sibiricus L.  Nippon Yakurigaku Zasshi (Folia Pharmacologica Japonica). 1930;  11 153-167
    PubMedGoogle Scholar
  • 41 Gulabov A Z, Tchervenkova-Veleva V B. On the structure of alcaloids from Leonurus cardiaca L.  Travaux scientifiques – Chimie. 1970;  8 129-132
    PubMedGoogle Scholar

1 These two authors contributed equally.

Prof. Dr. Stefan Dhein

Clinic for Cardiac Surgery
University of Leipzig

Struempellstrasse 39

04289 Leipzig

Germany

Phone: + 49 34 18 65 16 51

Fax: + 49 34 18 65 14 52

Email: dhes@medizin.uni-leipzig.de

Prof. Dr. Hans Wilhelm Rauwald

Chair of Pharmaceutical Biology
University of Leipzig

Johannisallee 21–23

04103 Leipzig

Germany

Phone: + 49 34 19 73 69 51

Fax: + 49 34 59 73 69 59

Email: rauwald@rz.uni-leipzig.de

      >